Amebiasis Treatment Market INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016–2024
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Amebiasis Treatment Market : Overview Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain. Amebiasis is common in regions with low developed sanitation facilities such as Asia Pacific, Central America, South America, and some parts of Africa. Amebiasis is mainly transmitted through water or food contaminated with Entamoeba Histolytica. Amebiasis can lead to diarrhea (with or without blood) in both adults and children, leading to high morbidity and mortality. The organism, Entamoeba Histolytica, can damage organ and may require surgical intervention, if the colon and other tissues have undergone perforation. However, amebiasis can be treated with some antibiotic, anti- parasitic, and antiprotozoal drugs such as metronidazole, paromomycin, and tinidazole. Diagnosis of this disease is usually made by microscopic identification of the microorganism in a stool specimen.
Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Amebiasis Treatment Market : Taxonomy Increasing approvals and launches of new drugs indicated for the treatment of amebiasis is expected to be a major factor for growth of amebiasis treatment market. For instance, in 2017, Dr. Reddy's Laboratories received U.S. Food and Drug Administration (FDA) approval for its Minolira (minocycline) extendedrelease tablets, indicated for the treatment of a variety of bacterial infections and as adjunctive therapy in acute intestinal amebiasis. Moreover, in 2016, Rising Pharmaceuticals, Inc.—a subsidiary of Aceto Corporation—launched Metronidazole Tablets, 250mg and 500mg, generic version of Flagyl manufactured by G.D. Searle, LLC’s, indicated for the treatment of amebiasis and a variety of anaerobic bacterial infections. In 2016, Mylan Pharmaceuticals Inc. received ANDA approval for its Doryx (Doxycycline Hyclate) Delayed-Release Tablets, 50 mg, indicated for the treatment of acute intestinal amebiasis. Get The Holistic SAMPLE:
https://www.coherentmarketinsights.com/insight/request-sample/1595 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Amebiasis Treatment Market : Key Players ● ● ● ● ● ● ● ● ● ●
Pfizer Inc. Impax Laboratories Lupin Pharmaceuticals, Inc. Sanofi Actelion Pharmaceuticals Ltd. Glenmark Pharmaceuticals Sun Pharmaceutical Industries Inc. Heritage Pharmaceuticals Inc. Mission Pharmacal Co. Novel Laboratories
Get More Details About This Report: https://www.coherentmarketinsights.com/ongoing-insight/amebiasis-treatment -market-1595 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES Š Coherent market Insights. All Rights Reserved
CUSTOMIZED RESEARCH CONSULT STUDIES
SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
MEDICAL DEVICES
MEDICAL IMAGING
OUR CLIENTS
Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
HEALTHCARE IT
PHARMACEUTICAL
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY STUDIES
GLOBAL REPORTS
100+ Insights Published Per Year
150+ Consulting Projects Till Date
125+
COUNTRY ANALYSIS
CONSULT PROJECTS
SURVEY RESEAR CH
EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT
Clients Worldwide Per Year
110+
TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 Š Coherent market Insights. All Rights Reserved